Senior Vice President, CMC Development

Steven Chamow, PhD

Boston, USA

Dr. Steven Chamow is a recognized expert in monoclonal antibodies and derivatives. He served as president of CMC advisory firm Chamow & Associates, acquired by Alira Health in 2021. Over his career, he has contributed to the development of four marketed biologics. Accolades include notable work at Intradigm, Genitope, Abgenix and Genentech. He earned degrees at the University of California (B.A. Santa Cruz, PhD. Davis) and did postdoctoral training at NIH.

Highlights

Years in industry icon
34+
of years in the industry
50
of publications
Board and committee positions icon
6+
of board or advisory committee positions

Key areas of expertise

  • Monoclonal Antibodies and Derivatives
  • Characterization and Analysis of Biologics
  • Recombinant Glycoprotein Production
  • Scale Up and GMP Manufacture of Biologics

Languages spoken

United Kingdom flag icon English

Our locations around the globe

Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.